JP2002515118A - 付加物保護分析 - Google Patents
付加物保護分析Info
- Publication number
- JP2002515118A JP2002515118A JP50074597A JP50074597A JP2002515118A JP 2002515118 A JP2002515118 A JP 2002515118A JP 50074597 A JP50074597 A JP 50074597A JP 50074597 A JP50074597 A JP 50074597A JP 2002515118 A JP2002515118 A JP 2002515118A
- Authority
- JP
- Japan
- Prior art keywords
- label
- aryl
- analyte
- group
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 66
- 239000000654 additive Substances 0.000 title description 9
- 230000000996 additive effect Effects 0.000 title description 9
- 230000027455 binding Effects 0.000 claims abstract description 103
- 239000012491 analyte Substances 0.000 claims abstract description 66
- 239000003446 ligand Substances 0.000 claims abstract description 54
- 238000003556 assay Methods 0.000 claims abstract description 21
- 230000004075 alteration Effects 0.000 claims abstract description 15
- 239000000523 sample Substances 0.000 claims description 108
- 238000000034 method Methods 0.000 claims description 66
- 125000003118 aryl group Chemical group 0.000 claims description 59
- 150000007523 nucleic acids Chemical group 0.000 claims description 36
- 238000004519 manufacturing process Methods 0.000 claims description 34
- -1 metaarsenite Chemical compound 0.000 claims description 31
- 229910052717 sulfur Inorganic materials 0.000 claims description 31
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 125000003545 alkoxy group Chemical group 0.000 claims description 25
- 125000003342 alkenyl group Chemical group 0.000 claims description 23
- 108020004707 nucleic acids Proteins 0.000 claims description 18
- 102000039446 nucleic acids Human genes 0.000 claims description 18
- 125000000304 alkynyl group Chemical group 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 239000011593 sulfur Substances 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 108091034117 Oligonucleotide Proteins 0.000 claims description 12
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 125000004104 aryloxy group Chemical group 0.000 claims description 11
- 125000004122 cyclic group Chemical group 0.000 claims description 11
- 239000003574 free electron Substances 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 claims description 10
- SITVSCPRJNYAGV-UHFFFAOYSA-L tellurite Chemical group [O-][Te]([O-])=O SITVSCPRJNYAGV-UHFFFAOYSA-L 0.000 claims description 10
- 125000004434 sulfur atom Chemical group 0.000 claims description 9
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 8
- 150000001408 amides Chemical group 0.000 claims description 8
- 239000002853 nucleic acid probe Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 150000003573 thiols Chemical group 0.000 claims description 7
- 229910052785 arsenic Inorganic materials 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- WDXYVJKNSMILOQ-UHFFFAOYSA-N 1,3,2-dioxathiolane 2-oxide Chemical compound O=S1OCCO1 WDXYVJKNSMILOQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 5
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 4
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 claims description 4
- 150000003017 phosphorus Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000003463 sulfur Chemical class 0.000 claims description 4
- 150000003567 thiocyanates Chemical class 0.000 claims description 4
- 229910052796 boron Inorganic materials 0.000 claims description 3
- 150000001638 boron Chemical class 0.000 claims description 3
- GCPXMJHSNVMWNM-UHFFFAOYSA-N arsenous acid Chemical group O[As](O)O GCPXMJHSNVMWNM-UHFFFAOYSA-N 0.000 claims 6
- 150000002825 nitriles Chemical class 0.000 claims 3
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims 3
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 claims 2
- 230000031700 light absorption Effects 0.000 claims 2
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical group COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 230000000977 initiatory effect Effects 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 description 40
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 32
- 238000001514 detection method Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 24
- 230000007062 hydrolysis Effects 0.000 description 22
- 238000006460 hydrolysis reaction Methods 0.000 description 22
- 238000009396 hybridization Methods 0.000 description 21
- 230000008859 change Effects 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 16
- 235000010265 sodium sulphite Nutrition 0.000 description 16
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 15
- 125000004429 atom Chemical group 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 9
- DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002372 labelling Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 239000003999 initiator Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000012038 nucleophile Substances 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- WAHQBNXSPALNEA-UHFFFAOYSA-L lithium succinate Chemical compound [Li+].[Li+].[O-]C(=O)CCC([O-])=O WAHQBNXSPALNEA-UHFFFAOYSA-L 0.000 description 4
- 229960004254 lithium succinate Drugs 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000002560 nitrile group Chemical group 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 210000002925 A-like Anatomy 0.000 description 2
- OAPPEBNXKAKQGS-UHFFFAOYSA-N Benz[c]acridine Chemical compound C1=CC=C2C3=NC4=CC=CC=C4C=C3C=CC2=C1 OAPPEBNXKAKQGS-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- AQLMHYSWFMLWBS-UHFFFAOYSA-N arsenite(1-) Chemical compound O[As](O)[O-] AQLMHYSWFMLWBS-UHFFFAOYSA-N 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- HOOSGZJRQIVJSZ-NNBUQUNQSA-N clidinium Chemical class C1([C@H]2CC[N@+](CC2)(C1)C)OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 HOOSGZJRQIVJSZ-NNBUQUNQSA-N 0.000 description 2
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-O isoquinolin-2-ium Chemical compound C1=[NH+]C=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-O 0.000 description 2
- YFVGRULMIQXYNE-UHFFFAOYSA-M lithium;dodecyl sulfate Chemical compound [Li+].CCCCCCCCCCCCOS([O-])(=O)=O YFVGRULMIQXYNE-UHFFFAOYSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical compound SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- JEGZRTMZYUDVBF-UHFFFAOYSA-N Benz[a]acridine Chemical compound C1=CC=C2C3=CC4=CC=CC=C4N=C3C=CC2=C1 JEGZRTMZYUDVBF-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000819038 Chichester Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- QECVIPBZOPUTRD-UHFFFAOYSA-N N=S(=O)=O Chemical class N=S(=O)=O QECVIPBZOPUTRD-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- GYUDLEOKVQWEHB-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21.C1=CC=CC2=CC3=CC=CC=C3N=C21 GYUDLEOKVQWEHB-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- JZYMCIPZZLIJKR-UHFFFAOYSA-N benzo[b]acridine Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3N=C21 JZYMCIPZZLIJKR-UHFFFAOYSA-N 0.000 description 1
- 150000005347 biaryls Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical class [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960003154 clidinium Drugs 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- ALVPFGSHPUPROW-UHFFFAOYSA-N dipropyl disulfide Chemical compound CCCSSCCC ALVPFGSHPUPROW-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- WCDWBPCFGJXFJZ-UHFFFAOYSA-N etanidazole Chemical group OCCNC(=O)CN1C=CN=C1[N+]([O-])=O WCDWBPCFGJXFJZ-UHFFFAOYSA-N 0.000 description 1
- ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 229910021476 group 6 element Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- AHKZTVQIVOEVFO-UHFFFAOYSA-N oxide(2-) Chemical compound [O-2] AHKZTVQIVOEVFO-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical group O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- BFPJYWDBBLZXOM-UHFFFAOYSA-L potassium tellurite Chemical compound [K+].[K+].[O-][Te]([O-])=O BFPJYWDBBLZXOM-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012106 screening analysis Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- AALQBIFJJJPDHJ-UHFFFAOYSA-K trisodium;thiophosphate;dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=S AALQBIFJJJPDHJ-UHFFFAOYSA-K 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 試料中の分析物のための分析方法であって、 a)分析物結合領域と標識とを含む標識された結合パートナーに上記試料を露 出する工程であって、上記標識された結合パートナーが上記分析物に結合する際 に、上記標識からのシグナル産生がシグナル変更リガンドによる変更から優先的 に保護される工程; b)上記結合パートナーに露出した上記試料を上記リガンドで処理する工程; そして c)変更されなかった標識から産生したシグナルを検出する工程 を含む上記の方法。 2. 上記結合パートナーが核酸プローブであり、上記分析物が標的核酸配列 である、請求の範囲第1項記載の方法。 3. 上記分析を、上記分析物に結合した結合パートナーを上記分析物に結合 していない結合パートナーから分離することなく実施する、請求の範囲第1項記 載の方法。 4. 上記工程(c)の前に上記分析物に結合した結合パートナーを上記分析 物に結合していない結合パートナーから分離することをさらに含む、請求の範囲 第1項記載の方法。 5. 上記工程(b)および(c)を本質的に一定な温度で実施する、請求の 範囲第1項記載の方法。 6. 上記分析をほぼ室温で実施する、請求の範囲第5項記載の方法。 7. 光吸収を上記工程(c)で検出する、請求の範囲第1項記載の方法。 8. 光放出を上記工程(c)で検出する、請求の範囲第1項記載の方法。 9. 上記リガンドが、遊離電子対を有する硫黄原子、遊離電子対を有する亜 テルル酸塩原子、または遊離電子対を有する亜ヒ酸塩原子のいずれかを含み、上 記硫黄原子、上記亜テルル酸塩原子、または上記亜ヒ酸塩原子は芳香環またはニ トリルに共役していない、請求の範囲第1項記載の方法。 10. 上記リガンドが、テトラヒドロチオペン、プロパンチオール、ベンジ ルメルカプタン、亜硫酸塩、亜硫酸グリコール、ヒドロ亜硫酸塩、メタ重亜硫酸 塩、チオ硫酸塩、チオリン酸塩、メタ亜ヒ酸塩、亜テルル酸塩、亜ヒ酸塩、およ びチオシアネートから成る群から選択される、請求の範囲第1項記載の方法。 11. 上記リガンドが、遊離電子対を有する硫黄原子、遊離電子対を有する 亜テルル酸塩原子、または遊離電子対を有する亜ヒ酸塩原子のいずれかを含み、 上記硫黄原子、上記亜テルル酸塩原子、または上記亜ヒ酸塩原子は芳香環または ニトリルに共役していない、請求の範囲第8項記載の方法。 12. 上記リガンドが、テトラヒドロチオペン、プロパンチオール、ベンジ ルメルカプタン、亜硫酸塩、亜硫酸グリコール、ヒドロ亜硫酸塩、メタ重亜硫酸 塩、チオ硫酸塩、チオリン酸塩、メタ亜ヒ酸塩、亜テルル酸塩、亜ヒ酸塩、およ びチオシアネートから成る群から選択される、請求の範囲第8項記載の方法。 13. 上記標識が以下の化学構造を有する請求の範囲第1項記載の方法: (式中、アリール環系は1〜4個の環式基を含み、上記の基の1つは結合炭素「 c」に結合しており、 R2は、S、O、およびNHから成る群から選択され; R3は、O、N、S、ハロゲン、置換したリン、置換した硫黄、置換したホウ 素、および置換したヒ素から成る群から選択され; R4は、アルキル、アルケニル、アリール、アルコキシ、アリールオキシから 成る群から選択され、R3がハロゲンの場合には存在せず; R5は、R3がNでない場合には存在せず、R3がNの場合にはR5は水素、アル キル、アルケニル、アリール、アルコキシ、およびアリールオキシから成る群か ら選択される。) 14. 上記アリール系が正に帯電している、請求の範囲第13項記載の方法 。 15. 上記アリール環系が1〜4個の環式基を有し; 上記R3がO、N、およびSから成る群から選択され; 上記R4がアリールであり;そして 上記R5が存在しない、 請求の範囲第14項記載の方法。 16. 上記標識が以下の化学構造を有する、請求の範囲第15項記載の方法 : (式中、R1は、H、アルキル、アルケニル、アルキニル、およびアリールから 成る群から選択され; nは0、1、2、3、または4であり; mは0、1、2、3、または4であり; 各々のxは独立して、アルキル、アルケニル、アルキニル、アリール、アミノ 、置換アミノ、カルボキシ、ヒドロキシ、アルコキシ、ニトロ、スルホニル、ハ ロゲン、チオール、アミド、アセチル、置換アセチル、およびアリールオキシか ら成る群から選択され; 各々のyは独立して、アルキル、アルケニル、アルキニル、アリール、アミノ 、置換アミノ、カルボキシ、ヒドロキシ、アルコキシ、ニトロ、スルホニル、ハ ロゲン、チオール、アミド、アセチル、置換アセチル、およびアリールオキシか ら成る群から選択される。) 17. 上記nが0、1または2であり; 上記mが0、1または2であり; 上記R3がOであり; 上記R4がアリールであり:そして 上記R5が存在しない、 請求の範囲第16項記載の方法。 18. 上記Xの各々が独立してアルキルまたアルコキシであり; 上記Yの各々が独立してアルキルまたアルコキシであり;そして 上記R4が所望により置換されたフェニルである、 請求の範囲第17項記載の方法。 19. 上記R4が、オルト−メチル−シンナメート−フェニル、オルト−ジ メチル−フェニル、オルト−ジブロモ−フェニルおよび未置換フェニルから成る 群から選択される、請求の範囲第18項記載の方法。 20. 試料中の核酸標的領域のための分析方法であって、 a)上記標的領域に結合することができる核酸配列を有するオリゴヌクレオチ ドと標識とを含む核酸プローブに上記試料を露出する工程で、上記標識が上記標 的領域に結合したプローブ上に存在する場合、上記標識からのシグナル産生がシ グナル変更リガンドによる変更から優先的に保護される工程; b)上記プローブに露出した上記試料を上記リガンドで処理する工程;そして c)変更されなかった標識から産生したシグナルを検出する工程 を含む上記の方法。 21. 上記標的がRNAである、請求の範囲第20項記載の方法。 22. 上記分析を、上記分析物に結合したプローブを上記分析物に結合して いないプローブから分離することなく実施する、請求の範囲第20項記載の方法 。 23. 上記工程(c)の前に上記分析物に結合したプローブを上記分析物に 結合していないプローブから分離することをさらに含む、請求の範囲第20項記 載の方法。 24. 上記工程(b)および(c)を本質的に一定な温度で実施する、請求 の範囲第20項記載の方法。 25. 上記分析をほぼ室温で実施する、請求の範囲第24項記載の方法。 26. 光吸収を上記工程(c)で検出する、請求の範囲第20項記載の方法 。 27. 光放出を上記工程(c)で検出する、請求の範囲第20項記載の方法 。 28. 上記標識が以下の化学構造を有する請求の範囲第27項記載の方法: (式中、上記アリール環系は1〜4個の環式基を含み、上記の基の1つは結合炭 素「c」に結合したアリールであり; R2は、S、O、およびNHから成る群から選択され; R3は、O、N、S、ハロゲン、置換したリン、置換した硫黄、置換したホウ 素、および置換したヒ素から成る群から選択され; R4は、アルキル、アルケニル、アリール、アルコキシ、アリールオキシから 成る群から選択され、R3がハロゲンの場合には存在せず;そして R5は、R3がNでない場合には存在せず、R3がNの場合にはR5は水素、 アルキル、アルケニル、アリール、アルコキシ、およびアリールオキシから成る 群から選択される。) 29. 上記アリール系が正に帯電している、請求の範囲第28項記載の方法 。 30. 上記アリール環系が1〜4個の環式基を有し; 上記R3がO、N、およびSから成る群から選択され; 上記R4がアリールであり;そして 上記R5が存在しない、 請求の範囲第29項記載の方法。 31. 上記標識が以下の化学構造を有する、請求の範囲第30項記載の方法 (式中、R1は、H、アルキル、アルケニル、アルキニル、およびアリールから 成る群から選択され; nは0、1、2、3、または4であり; mは0、1、2、3、または4であり; 各々のxは独立して、アルキル、アルケニル、アルキニル、アリール、アミノ 、置換アミノ、カルボキシ、ヒドロキシ、アルコキシ、ニトロ、スルホニル、ハ ロゲン、チオール、アミド、アセチル、置換アセチル、およびアリールオキシか ら成る群から選択され;そして 各々のyは独立して、アルキル、アルケニル、アルキニル、アリール、アミノ 、 置換アミノ、カルボキシ、ヒドロキシ、アルコキシ、ニトロ、スルホニル、ハロ ゲン、チオール、アミド、アセチル、置換アセチル、およびアリールオキシから 成る群から選択される。) 32. 上記nが0、1または2であり; 上記mが0、1または2であり; 上記R3が0であり; 上記R4がアリールであり;そして 上記R5が存在しない、 請求の範囲第31項記載の方法。 33. 上記Xの各々が独立してアルキルまたアルコキシであり; 上記Yの各々が独立してアルキルまたアルコキシであり;そして 上記R4が所望により置換されたフェニルである、 請求の範囲第32項記載の方法。 34. 上記R4が、オルト−メチル−シンナメート−フェニル、オルト−ジ メチル−フェニル、オルト−ジブロモ−フェニルおよび未置換フェニルから成る 群から選択される、請求の範囲第33項記載の方法。 35. 上記リガンドが、テトラヒドロチオペン、プロパンチオール、ベンジ ルメルカプタン、亜硫酸塩、亜硫酸グリコール、ヒドロ亜硫酸塩、メタ重亜硫酸 塩、チオ硫酸塩、チオリン酸塩、メタ亜ヒ酸塩、亜テルル酸塩、亜ヒ酸塩、およ びチオシアネートから成る群から選択される、請求の範囲第20項記載の方法。 36. 上記リガンドが、遊離電子対を有する硫黄原子、遊離電子対を有する 亜テルル酸塩原子、または遊離電子対を有する亜ヒ酸塩原子のいずれかを含み、 上記硫黄原子、上記亜テルル酸塩原子、または上記亜ヒ酸塩原子は芳香環または ニトリルに共役していない、請求の範囲第20項記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/478,221 | 1995-06-07 | ||
US08/478,221 US5731148A (en) | 1995-06-07 | 1995-06-07 | Adduct protection assay |
PCT/US1996/007776 WO1996041197A1 (en) | 1995-06-07 | 1996-05-23 | Adduct protection assay |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002515118A true JP2002515118A (ja) | 2002-05-21 |
JP3577085B2 JP3577085B2 (ja) | 2004-10-13 |
Family
ID=23899023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50074597A Expired - Lifetime JP3577085B2 (ja) | 1995-06-07 | 1996-05-23 | 付加物保護分析 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5731148A (ja) |
EP (1) | EP0747706B1 (ja) |
JP (1) | JP3577085B2 (ja) |
KR (1) | KR19990022460A (ja) |
AT (1) | ATE246807T1 (ja) |
AU (1) | AU703605B2 (ja) |
CA (1) | CA2222556C (ja) |
DE (1) | DE69629333T2 (ja) |
DK (1) | DK0747706T3 (ja) |
ES (1) | ES2203656T3 (ja) |
WO (1) | WO1996041197A1 (ja) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714380A (en) | 1986-10-23 | 1998-02-03 | Amoco Corporation | Closed vessel for isolating target molecules and for performing amplification |
DE69736667T2 (de) * | 1996-07-16 | 2007-09-06 | Gen-Probe Inc., San Diego | Verfahren zum nachweis und amplifikation von nukleinsäuresequenzen unter verbrauch von modifizierten oligonukleotiden mit erhöhter zielschmelztemperatur (tm) |
US7070925B1 (en) | 1996-07-16 | 2006-07-04 | Gen-Probe Incorporated | Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe |
CA2286304C (en) | 1997-04-10 | 2007-08-07 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
US6534273B2 (en) | 1997-05-02 | 2003-03-18 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
WO1998050583A1 (en) | 1997-05-02 | 1998-11-12 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
US6180340B1 (en) | 1997-10-31 | 2001-01-30 | Gen-Probe Incorporated | Extended dynamic range assays |
WO1999049293A2 (en) | 1998-03-24 | 1999-09-30 | Boston Probes, Inc. | Methods, kits and compositions pertaining to detection complexes |
US6361945B1 (en) | 1998-07-02 | 2002-03-26 | Gen-Probe Incorporated | Molecular torches |
US5998175A (en) * | 1998-07-24 | 1999-12-07 | Lumigen, Inc. | Methods of synthesizing and amplifying polynucleotides by ligation of multiple oligomers |
ATE448324T1 (de) | 1999-02-12 | 2009-11-15 | Gen Probe Inc | Schutzsonden |
ATE421999T1 (de) | 1999-07-09 | 2009-02-15 | Gen Probe Inc | Nachweis von hiv-1 durch amplifizierung von nukleinsäuren |
US6506887B1 (en) * | 1999-07-29 | 2003-01-14 | Somalogic, Incorporated | Conditional-selex |
EP1222266B1 (en) | 1999-09-29 | 2006-03-29 | Diagnocure Inc. | Pca3 messenger rna in benign and malignant prostate tissues |
US6506567B2 (en) * | 2000-01-31 | 2003-01-14 | Fuji Photo Film Co., Ltd. | Water-soluble flourescent intercalator compound |
CN1250741C (zh) * | 2000-02-03 | 2006-04-12 | 研究发展基金会 | 将分子识别转导成不同信号的信号适体 |
EP1377679B1 (en) * | 2000-12-14 | 2009-10-28 | Gen-Probe Incorporated | Method and kit for enhancing the association rates of polynucleotides |
JP4299540B2 (ja) | 2001-01-23 | 2009-07-22 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | C型肝炎ウイルスレプリコンおよびレプリコン増強細胞 |
US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
ES2370169T3 (es) | 2002-06-14 | 2011-12-13 | Gen-Probe Incorporated | Composiciones y métodos para detectar el virus de la hepatitis b. |
CA2868618C (en) | 2002-10-16 | 2017-05-23 | Gen-Probe Incorporated | Compositions and methods for detecting west nile virus |
CA2513780C (en) | 2003-02-07 | 2014-12-30 | Diagnocure Inc. | Method to detect prostate cancer from a urine sample |
US20060257929A1 (en) * | 2003-11-12 | 2006-11-16 | Microbiosystems, Limited Partnership | Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins |
ATE478968T1 (de) | 2003-12-19 | 2010-09-15 | Gen Probe Inc | Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2 |
NZ549622A (en) | 2004-02-18 | 2010-09-30 | Chromocell Corp | Methods and materials using signaling probes |
WO2005100538A1 (en) * | 2004-04-16 | 2005-10-27 | Spartan Bioscience Inc. | System for rapid nucleic acid amplification and detection |
DK1778867T3 (da) * | 2004-07-01 | 2010-08-02 | Gen Probe Inc | Fremgangsmåder og sammensætninger til detektering af nucleinsyrer i en biologisk prøve |
JP4753943B2 (ja) | 2004-07-13 | 2011-08-24 | ジェン−プローブ・インコーポレーテッド | A型肝炎ウイルス核酸の検出のための組成物及び方法 |
US20060068380A1 (en) | 2004-09-30 | 2006-03-30 | Gen-Probe Incorporated | Assay for detecting and quantifying HIV-1 |
JP5192238B2 (ja) | 2004-11-09 | 2013-05-08 | ジェン−プローブ・インコーポレーテッド | A群連鎖球菌属を検出するための組成物及び方法 |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
EP1877581B1 (en) | 2005-05-06 | 2012-03-28 | Gen-Probe Incorporated | Methods and products for nucleic acid target capture |
CA2605015C (en) | 2005-05-06 | 2013-09-10 | Gen-Probe Incorporated | Compositions and assays to detect influenza virus a and b nucleic acids |
US20080220432A1 (en) * | 2006-11-30 | 2008-09-11 | Chromocell Corporation | Optimized host cells for protein production |
EP1978111B1 (en) | 2007-04-02 | 2013-03-27 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of Pseudomonas aeruginosa |
EP2465609B1 (en) | 2007-06-21 | 2016-12-28 | Gen-Probe Incorporated | Method for mixing the contents of a detection chamber |
EP3392351A1 (en) | 2008-04-21 | 2018-10-24 | Gen-Probe Incorporated | Method for detecting chikungunya virus |
WO2009140374A2 (en) | 2008-05-13 | 2009-11-19 | Gen-Probe Incorporated | Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
EP2297358A2 (en) | 2008-05-30 | 2011-03-23 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of salmonella |
US8097412B2 (en) * | 2008-07-12 | 2012-01-17 | Biodiagnostics, Inc. | DNA-based test for detection of annual and intermediate ryegrass |
CA2638458A1 (en) * | 2008-07-31 | 2010-01-31 | Spartan Bioscience Inc. | Thermal recycling by positioning relative to fixed-temperature source |
AU2009324884B2 (en) | 2008-11-25 | 2013-10-03 | Gen-Probe Incorporated | Compositions and methods for detecting small RNAs, and uses thereof |
US8748133B2 (en) | 2008-12-30 | 2014-06-10 | Gen-Probe Incorporated | Compositions, kits and related methods for the detection and/or monitoring of Listeria |
US8368882B2 (en) | 2009-01-30 | 2013-02-05 | Gen-Probe Incorporated | Systems and methods for detecting a signal and applying thermal energy to a signal transmission element |
EP3705486B1 (en) | 2009-02-26 | 2022-11-16 | Gen-Probe Incorporated | Assay for detection of human parvovirus nucleic acid |
AU2011272868B2 (en) | 2010-06-30 | 2015-09-17 | Gen-Probe Incorporated | Method and apparatus for identifying analyte-containing samples using single-read determination of analyte and process control signals |
EP2593569B1 (en) | 2010-07-12 | 2018-01-03 | Gen-Probe Incorporated | Compositions and assays to detect seasonal h1 influenza a virus nucleic acids |
EP2616555B1 (en) | 2010-09-16 | 2017-11-08 | Gen-Probe Incorporated | Capture probes immobilizable via l-nucleotide tail |
EP3438289A1 (en) | 2010-10-04 | 2019-02-06 | Gen-Probe Prodesse, Inc. | Compositions, methods and kits to detect adenovirus nucleic acids |
CA3113828A1 (en) | 2011-07-15 | 2013-01-24 | Gen-Probe Incorporated | Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays |
DE102011120550B4 (de) | 2011-12-05 | 2013-11-07 | Gen-Probe Prodesse, Inc. | Zusammensetzungen, Verfahren und Kits zur Detektion von Adenovirusnukleinsäuren |
EP2971131A4 (en) | 2013-03-15 | 2016-11-23 | Chromocell Corp | METHODS AND MATERIALS USING SIGNALING PROBES |
EP3209799B1 (en) | 2014-10-20 | 2020-07-08 | Gen-Probe Incorporated | Red blood cell lysis solution |
WO2017098321A1 (en) | 2015-12-11 | 2017-06-15 | Spartan Bioscience Inc. | Tube sealing system and methods for nucleic acid amplification |
EP3448998B1 (en) | 2016-04-27 | 2020-06-03 | Gen-Probe Incorporated | Blood cell lysis reagent |
CA3176536C (en) | 2017-03-24 | 2024-03-05 | Gen-Probe Incorporated | Compositions and methods for detection of viral pathogens in samples |
CA3057154A1 (en) | 2017-03-24 | 2018-09-27 | Gen-Probe Incorporated | Compositions and methods for detecting or quantifying parainfluenza virus |
CA3056135C (en) | 2017-03-25 | 2024-02-20 | Gen-Probe Incorporated | Compositions, methods and kits to detect adenovirus nucleic acids |
CA3068994C (en) | 2017-07-10 | 2023-06-27 | Gen-Probe Incorporated | Analytical systems and methods for nucleic acid amplification using sample assigning parameters |
US11859257B2 (en) | 2017-08-11 | 2024-01-02 | Gen-Probe Incorporated | Compositions and methods for detecting Staphylococcus aureus |
EP3724354A1 (en) | 2017-12-15 | 2020-10-21 | Gen-Probe Incorporated | Compositions and methods for detecting toxigenic clostridium difficile |
JP2021512303A (ja) | 2018-01-29 | 2021-05-13 | ジェン−プローブ・インコーポレーテッド | 分析システムおよび方法 |
GB2590210B (en) | 2018-06-13 | 2023-01-25 | Gen Probe Inc | Compositions and methods for detecting group B Streptococcus nucleic acid |
US20210317515A1 (en) | 2018-07-10 | 2021-10-14 | Gen-Probe Incorporated | Methods and systems for detecting and quantifying nucleic acids |
CA3106975A1 (en) | 2018-08-01 | 2020-02-06 | Gen-Probe Incorporated | Compositions and methods for detecting nucleic acids of epstein-barr virus |
US20210310059A1 (en) | 2018-08-08 | 2021-10-07 | Gen-Probe Incorporated | Compositions, methods and kits for detecting mycoplasma genitalium |
WO2020041414A1 (en) | 2018-08-21 | 2020-02-27 | Gen-Probe Incorporated | Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus |
WO2020069085A2 (en) | 2018-09-27 | 2020-04-02 | Gen-Probe Incorporated | Compositions and methods for detecting bordetella pertussis and bordetella parapertussis nucleic acid |
EP3861141A1 (en) | 2018-10-01 | 2021-08-11 | Gen-Probe Incorporated | Compositions and methods for amplifying or detecting varicella-zoster virus |
CN113195743A (zh) | 2018-10-22 | 2021-07-30 | 简·探针公司 | 扩增,检测或定量人类多瘤病毒bk病毒的组合物和方法 |
US20220098647A1 (en) | 2019-03-22 | 2022-03-31 | Gen-Probe Incorporated | Compositions and Methods for Detecting Group A Streptococcus |
CN118125057A (zh) | 2019-05-03 | 2024-06-04 | 简·探针公司 | 用于分析系统的容器输送系统 |
US20220298548A1 (en) | 2019-08-23 | 2022-09-22 | Gen-Probe Incorporated | Compositions, methods and kits for detecting treponema pallidum |
WO2021046270A1 (en) | 2019-09-05 | 2021-03-11 | Gen-Probe Incorporated | Detection of chlamydia trachomatis nucleic acid variants |
US20230117369A1 (en) | 2020-03-04 | 2023-04-20 | Gen-Probe Incorporated | Compositions and methods for detecting sars-cov-2 nucleaic acid |
CN116323440A (zh) | 2020-10-21 | 2023-06-23 | 简·探针公司 | 流体容器管理系统 |
AU2022319876A1 (en) | 2021-07-27 | 2024-01-18 | Gen-Probe Incorporated | Compositions and methods for detecting gastrointestinal pathogens |
AU2023235558A1 (en) | 2022-03-15 | 2024-10-03 | Diagenode S.A. | Detection of methylation status of a dna sample |
WO2024054924A1 (en) | 2022-09-08 | 2024-03-14 | Gen-Probe Incorporated | Method of detecting nucleic acid analytes using dual-specificity primers |
WO2024137379A2 (en) | 2022-12-19 | 2024-06-27 | Gen-Probe Incorporated | Compositions and methods for detecting gastrointestinal pathogens |
WO2024192338A1 (en) | 2023-03-16 | 2024-09-19 | Gen-Probe Incorporated | Compositions and methods for detecting gastrointestinal parasites |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6515469A (ja) * | 1965-01-22 | 1966-07-25 | ||
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US4190496A (en) * | 1971-05-14 | 1980-02-26 | Syva Company | Homogeneous enzyme assay for antibodies |
US4199559A (en) * | 1974-08-12 | 1980-04-22 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4383031A (en) * | 1975-04-28 | 1983-05-10 | Miles Laboratories, Inc. | Homogeneous chemiluminescent specific binding assay |
US4174384A (en) * | 1975-06-30 | 1979-11-13 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
FR2422956A1 (fr) * | 1978-04-13 | 1979-11-09 | Pasteur Institut | Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede |
US4318707A (en) * | 1978-11-24 | 1982-03-09 | Syva Company | Macromolecular fluorescent quencher particle in specific receptor assays |
CA1185177A (en) * | 1981-07-17 | 1985-04-09 | Larry E. Morrison | Non-radiative energy transfer immunochemical technique |
CA1190838A (en) * | 1981-07-17 | 1985-07-23 | Cavit Akin | Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer |
US4668640A (en) * | 1981-12-11 | 1987-05-26 | Abbott Laboratories | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins |
GB2112779B (en) * | 1981-12-11 | 1986-10-15 | Welsh Nat School Med | Aryl acridinium esters as luminescent labelling materials |
US4462931A (en) * | 1982-06-16 | 1984-07-31 | American Cyanamid Company | Enhanced aqueous chemiluminescent systems |
US4508642A (en) * | 1983-04-21 | 1985-04-02 | World Victor B | Method of obtaining greater lifetime duration from chemiluminescent systems |
US4816419A (en) * | 1983-08-01 | 1989-03-28 | University Of Health Sciences/The Chicago Medical School | Fluorescence ligand binding assay using charge-matched dye and solvent components |
US4640898A (en) * | 1983-08-01 | 1987-02-03 | University Of Health Sciences/The Chicago Medical School | Homogeneous fluorescence ligang binding assay based upon preferential alteration of the respective intensities of bound and free label by solvent components |
US4582789A (en) * | 1984-03-21 | 1986-04-15 | Cetus Corporation | Process for labeling nucleic acids using psoralen derivatives |
AU580042B2 (en) * | 1984-03-22 | 1988-12-22 | Bresatec Limited | Non-radioactive biological probes |
CA1260372A (en) * | 1984-04-27 | 1989-09-26 | Elazar Rabbani | Hybridization method for the detection of genetic materials |
US4670379A (en) * | 1984-12-19 | 1987-06-02 | E. I. Du Pont De Nemours And Company | Polynucleotide hydridization assays employing catalyzed luminescence |
ATE40572T1 (de) * | 1985-01-10 | 1989-02-15 | Molecular Diagnostics Inc | Photochemisches verfahren zum markieren von nucleinsaeuren zum nachweis in hybridisationsproben. |
US4655969A (en) * | 1985-04-03 | 1987-04-07 | Richter Herbert P | Chemiluminescent systems |
JP2509574B2 (ja) * | 1985-08-15 | 1996-06-19 | アモコ・コーポレーション | 標識付けした核酸 |
JPS6261969A (ja) * | 1985-09-06 | 1987-03-18 | アモコ・コーポレーション | アクリジニウムエステルの合成法 |
DE3545398A1 (de) * | 1985-12-20 | 1987-06-25 | Boehringer Mannheim Gmbh | Verfahren zur steigerung der quanten-ausbeute bei der oxidation von luminol durch peroxide in gegenwart von peroxidase |
US4698183A (en) * | 1986-02-04 | 1987-10-06 | American Cyanamid Company | High light output-short duration chemiluminescent compositions |
DE3645292C2 (de) * | 1986-08-22 | 1997-12-11 | Hoechst Ag | Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung |
US4918192A (en) * | 1986-10-06 | 1990-04-17 | Ciba Corning Diagnostics Corp. | Polysubstituted aryl acridinium esters |
US4745181A (en) * | 1986-10-06 | 1988-05-17 | Ciba Corning Diagnostics Corp. | Polysubstituted aryl acridinium esters |
US5110932A (en) * | 1986-10-06 | 1992-05-05 | Ciba Corning Diagnostics Corp. | Polysubstituted aryl acridinium esters |
ES2063735T3 (es) * | 1986-10-22 | 1995-01-16 | Abbott Lab | Sales de acridinio quimioluminiscentes. |
JPS63107898A (ja) * | 1986-10-23 | 1988-05-12 | Natl Inst For Res In Inorg Mater | プラズマを用いるダイヤモンドの合成法 |
US4927769A (en) * | 1987-07-08 | 1990-05-22 | Ciba Corning Diagnostics Corp. | Method for enhancement of chemiluminescence |
US5283174A (en) * | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
PT88550A (pt) * | 1987-09-21 | 1989-07-31 | Ml Tecnology Ventures Lp | Processo para a preparacao de reagentes de ligacao nao nucleotidicos para sondas nucleotidicas |
EP0638807B1 (en) * | 1987-09-21 | 2002-07-17 | Gen-Probe Incorporated | Protection assay |
US5185439A (en) * | 1987-10-05 | 1993-02-09 | Gen-Probe Incorporated | Acridinium ester labelling and purification of nucleotide probes |
US4883898A (en) * | 1987-12-10 | 1989-11-28 | University Of Chicago | Chemiluminescent compounds |
NL8703075A (nl) * | 1987-12-18 | 1989-07-17 | Nederlanden Staat | Acridiniumverbindingen als chemiluminescentie-merkstof. |
US5338847A (en) * | 1987-12-31 | 1994-08-16 | London Diagnostics, Inc. | Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation |
US5281712A (en) * | 1987-12-31 | 1994-01-25 | London Diagnostics, Inc. | Ammonium substituted chemiluminescent labels and their conjugates, and assays therefrom |
US5321136A (en) * | 1987-12-31 | 1994-06-14 | London Diagnostics, Inc. | Peri substituted fused ring chemiluminescent labels and their conjugates, and assays therefrom |
NZ227506A (en) * | 1987-12-31 | 1992-06-25 | London Diagnostics Inc | Specific binding assays using chemiluminescent compounds |
DE3844954C2 (de) * | 1988-02-20 | 1998-07-16 | Hoechst Ag | Spezielle chemilumineszierende Acridinderivate und ihre Verwendung in Lumineszenzimmunoassays |
US4950613A (en) * | 1988-02-26 | 1990-08-21 | Gen-Probe Incorporated | Proteted chemiluminescent labels |
AU634716B2 (en) * | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
US5241070A (en) * | 1988-09-26 | 1993-08-31 | Ciba Corning Diagnostics Corp. | Nucleophilic polysubstituted aryl acridinium esters and uses thereof |
CA1339491C (en) * | 1988-09-26 | 1997-10-07 | Say-Jong Law | Nucleophilic polysubstituted aryl acridinium ester and uses thereof |
US5093270A (en) * | 1989-05-24 | 1992-03-03 | Ciba Corning Diagnostics Corp. | Method for enhancing signal release from liposomes using water-miscible alcohols |
GB2233451B (en) * | 1989-06-27 | 1993-09-15 | Tropix Inc | Chemiluminescence enhancement |
JPH0335147A (ja) * | 1989-07-03 | 1991-02-15 | Doujin Kagaku Kenkyusho:Kk | 化学発光の検出 |
ES2124231T3 (es) * | 1990-10-26 | 1999-02-01 | Genta Inc | Procedimiento mejorado para sintesis de oligomeros. |
WO1992009580A1 (en) * | 1990-11-21 | 1992-06-11 | Beckman Instruments, Inc. | Chemiluminescent compounds |
DE69132765T2 (de) * | 1990-12-24 | 2002-02-21 | Enzo Diagnostics, Inc. | Verfahren zum Nachweis eines Zielpolynukleotids in einer Probe unter Verwendung eines Reagenz, das den Hintergrund verringert, und eine dieses Reagenz enthaltende Zusammensetzung und Kit. |
JPH0579985A (ja) * | 1991-09-24 | 1993-03-30 | Kyoto Daiichi Kagaku:Kk | 化学発光増強剤及び増強方法 |
JPH05255264A (ja) * | 1992-03-13 | 1993-10-05 | Sanyo Chem Ind Ltd | 標識剤および標識されたリガンドの製法 |
KR950701392A (ko) * | 1992-05-06 | 1995-03-23 | 다니엘 엘. 카시안 | 인체 B형 간염 바이러스에 대한 핵산 증폭 올리고뉴클레오티드 및 프로브(Nucleic Acide Amplification Oligonucleotides and Probes to Human Hepatitis B Birus) |
JP3248628B2 (ja) * | 1992-06-25 | 2002-01-21 | 国際試薬株式会社 | 化学発光性化合物およびこれを用いるアッセイ法 |
WO1994002486A1 (en) * | 1992-07-20 | 1994-02-03 | Syntex (U.S.A.) Inc. | Novel chemiluminescent compounds and methods of use |
JP3207933B2 (ja) * | 1992-09-09 | 2001-09-10 | 株式会社ヤトロン | アクリジニウム誘導体の発光方法及びそれを用いた検査対象物質の検出方法 |
EP0602524A1 (de) * | 1992-12-15 | 1994-06-22 | Hoechst Aktiengesellschaft | Chemilumineszenzmarkierte Gensonden und ihre Verwendung in Gensondentesten |
JP3584379B2 (ja) * | 1993-02-04 | 2004-11-04 | 持田製薬株式会社 | アクリジニウム化合物およびアクリジニウム化合物複合体 |
JP4108118B2 (ja) * | 1993-03-26 | 2008-06-25 | ジェン−プローブ・インコーポレイテッド | ヒト・免疫不全ウイルス1型の検出 |
US5491072A (en) * | 1993-05-17 | 1996-02-13 | Lumigen, Inc. | N-alkylacridan carboxyl derivatives useful for chemiluminescent detection |
AU692816B2 (en) * | 1993-07-19 | 1998-06-18 | Gen-Probe Incorporated | Oligonucleotide screening assay |
JPH07330838A (ja) * | 1994-06-10 | 1995-12-19 | Nippon Oil & Fats Co Ltd | アクリダン基含有高分子および化学発光方法 |
JP3694044B2 (ja) * | 1994-06-22 | 2005-09-14 | 株式会社三菱化学ヤトロン | アクリジニウム誘導体の発光方法及びその方法を用いた検査対象物質の検出方法 |
DE69535240T2 (de) * | 1994-10-28 | 2007-06-06 | Gen-Probe Inc., San Diego | Zusammensetzungen und Verfahren für die gleichzeitige Detektion und Quantifizierung von einer Mehrheit spezifischer Nuklein Säure Sequenzen |
-
1995
- 1995-06-07 US US08/478,221 patent/US5731148A/en not_active Expired - Lifetime
-
1996
- 1996-05-23 AU AU60244/96A patent/AU703605B2/en not_active Ceased
- 1996-05-23 WO PCT/US1996/007776 patent/WO1996041197A1/en not_active Application Discontinuation
- 1996-05-23 CA CA002222556A patent/CA2222556C/en not_active Expired - Fee Related
- 1996-05-23 JP JP50074597A patent/JP3577085B2/ja not_active Expired - Lifetime
- 1996-05-23 KR KR1019970708941A patent/KR19990022460A/ko not_active Application Discontinuation
- 1996-06-03 DK DK96108880T patent/DK0747706T3/da active
- 1996-06-03 EP EP96108880A patent/EP0747706B1/en not_active Expired - Lifetime
- 1996-06-03 ES ES96108880T patent/ES2203656T3/es not_active Expired - Lifetime
- 1996-06-03 AT AT96108880T patent/ATE246807T1/de not_active IP Right Cessation
- 1996-06-03 DE DE69629333T patent/DE69629333T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5731148A (en) | 1998-03-24 |
ATE246807T1 (de) | 2003-08-15 |
DK0747706T3 (da) | 2003-11-24 |
DE69629333D1 (de) | 2003-09-11 |
CA2222556A1 (en) | 1996-12-19 |
WO1996041197A1 (en) | 1996-12-19 |
KR19990022460A (ko) | 1999-03-25 |
EP0747706B1 (en) | 2003-08-06 |
EP0747706A1 (en) | 1996-12-11 |
DE69629333T2 (de) | 2004-06-24 |
ES2203656T3 (es) | 2004-04-16 |
CA2222556C (en) | 2002-06-11 |
AU703605B2 (en) | 1999-03-25 |
JP3577085B2 (ja) | 2004-10-13 |
AU6024496A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002515118A (ja) | 付加物保護分析 | |
KR960002561B1 (ko) | 균질보호분석법 | |
US5827653A (en) | Nucleic acid detection with energy transfer | |
JP4438110B2 (ja) | 標的核酸の定量方法 | |
US4775619A (en) | Polynucleotide determination with selectable cleavage sites | |
WO1996041197A9 (en) | Adduct protection assay | |
US6566068B2 (en) | Process for detecting a nucleic acid of interest using an oligo- or polynucleotide probe and intercalators | |
Zhang et al. | Time-resolved probes based on guanine/thymine-rich DNA-sensitized luminescence of terbium (III) | |
US5948899A (en) | Compositions for homogenous protection assay | |
US5283174A (en) | Homogenous protection assay | |
CA1340231C (en) | Polynucleotede dertermination with selectable cleavage sites | |
US7576192B2 (en) | Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors | |
Perrier et al. | Panoply of fluorescence polarization/anisotropy signaling mechanisms for functional nucleic acid-based sensing platforms | |
Browne et al. | Simultaneous quantification of multiple nucleic acid targets using chemiluminescent probes | |
Huang et al. | Multiplex detection of endonucleases by using a multicolor gold nanobeacon | |
EP1478775A2 (en) | A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins | |
CA2591652A1 (en) | Id-tag complexes, arrays, and methods of use thereof | |
Saneyoshi et al. | Long-lived luminogenic probe for detection of RNA in a crude solution of living bacterial cells | |
Kang et al. | Enzymatic cleavage and mass amplification strategy for small molecule detection using aptamer-based fluorescence polarization biosensor | |
JPH02504109A (ja) | 酵素活性測定方法 | |
WO2003064657A1 (en) | A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors | |
Shahmuradyan et al. | based platform for detection by hybridization using intrinsically labeled fluorescent oligonucleotide probes on quantum dots | |
US5466578A (en) | Surfactant-enhanced light emission- or absorbance-based binding assays for polynucleic acids | |
JPH06509707A (ja) | 選択可能な開裂部位を用いるポリヌクレオチド確認法 | |
Lopez-Crapez et al. | A homogeneous resonance energy transfer-based assay to monitor MutS/DNA interactions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040127 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040315 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040428 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040629 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040709 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070716 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080716 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090716 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100716 Year of fee payment: 6 |